3,4-dihydrobenzopyran compounds and pharmaceutical composition c

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514337, 546256, 546269, C07D40512, A61K 31455

Patent

active

046818901

ABSTRACT:
Novel 3,4-dihydrobenzopyran compounds of the formula: ##STR1## wherein R.sup.1, R.sup.2 and R.sup.3 are each hydrogen or nicotinoyl group and at least one of them is nicotinoyl group, m is an integer of 0, 1 or 2, and n is an integer of 0 or 1, which is useful for prophylaxis and treatment of hyperlipemia and the compounds wherein R.sup.1 and R.sup.3 being nicotinoyl group and n is 0 being also effective for prophylaxis and treatment of hepatic diseases, and pharmaceutical composition containing said compounds as an active ingredient.

REFERENCES:
Chemical Abstracts 94:30568z (1981).
Chemical Abstracts 98:4474d (1983).
Chemical Abstracts 86:161293p (1977).
Chemical Abstracts 86:133782d (1977).
Chemical Abstracts 88:11937d (1978).
Chemical Abstracts 96:19969b (1982).
Chemical Abstracts 97:216002c (1982).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

3,4-dihydrobenzopyran compounds and pharmaceutical composition c does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 3,4-dihydrobenzopyran compounds and pharmaceutical composition c, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3,4-dihydrobenzopyran compounds and pharmaceutical composition c will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-207606

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.